Tuesday, November 10, 2015
- 9:00AM-11:00AM
-
Abstract Number: 2736
Reduction of Disease Burden on Workplace and Household Productivity Following 52 Weeks of Treatment with Certolizumab Pegol in Combination with Methotrexate in DMARD-Naïve Patients with Active, Severe, Progressive Rheumatoid Arthritis
Rheumatoid Arthritis - Small Molecules, Biologics and Gene Therapy Poster III- 9:00AM-11:00AM
-
Abstract Number: 2569
Regulation of SIRT1 Maybe a Perfect Strategy in Treatment of Rheumatoid Arthritis
Rheumatoid Arthritis - Animal Models Poster- 9:00AM-11:00AM
-
Abstract Number: 2389
Relation of Pronated Foot Posture to Risk of Worsening Knee Pain during Gait and Compartment-Specific Knee Cartilage Damage
Osteoarthritis - Clinical Aspects Poster II: Biomarkers, Biomechanics and Health Services Research- 9:00AM-11:00AM
-
Abstract Number: 2305
Relationship Between Anxiety, Depression, Sleep, Fibromyalgia and BMI in Patients with Rheumatic Disease
Fibromyalgia, Soft Tissue Disorders, Regional and Specific Clinical Pain Syndromes Poster II- 9:00AM-11:00AM
-
Abstract Number: 2780
Relationship Between Immunogenicity, Hypersensitivity Reactions and Skin Tests Against Infliximab, Etanercept and Adalimumab in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis
Rheumatoid Arthritis - Small Molecules, Biologics and Gene Therapy Poster III- 9:00AM-11:00AM
-
Abstract Number: 2883
Relationship Between Improvements in Fatigue and Signs & Symptoms of Active Psoriatic: Arthritis a Sub-Analysis of a Phase 3 Study with Secukinumab
Spondylarthropathies and Psoriatic Arthritis - Clinical Aspects and Treatment Poster III: Therapy- 9:00AM-11:00AM
-
Abstract Number: 2593
Relationship Between Index of Activity Speed (Time Up and Go test) and Patient-Reported Outcome in Patients with Long-Standing Rheumatoid Arthritis: Multicenter Prospective Cohort Study for Evaluation of Joint Surgery on Physical Function
Rheumatoid Arthritis - Clinical Aspects Poster Session III- 9:00AM-11:00AM
-
Abstract Number: 2307
Relationship of Sleep Quality and Fibromyalgia Outcomes in a Phase 2b Randomized, Double-Blind, Placebo-Controlled Study of Bedtime, Rapidly Absorbed, Sublingual Cyclobenzaprine (TNX-102 SL)
Fibromyalgia, Soft Tissue Disorders, Regional and Specific Clinical Pain Syndromes Poster II- 9:00AM-11:00AM
-
Abstract Number: 2868
Relative Efficacy of Adalimumab Versus Secukinumab in Active Psoriatic Arthritis: A Matching-Adjusted Indirect Comparison
Spondylarthropathies and Psoriatic Arthritis - Clinical Aspects and Treatment Poster III: Therapy- 9:00AM-11:00AM
-
Abstract Number: 2961
Reliability and Validity of the Total Joint Count and Swollen Joint Count in Early Diffuse Systemic Sclerosis
Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Clinical Aspects and Therapeutics Poster III- 9:00AM-11:00AM
-
Abstract Number: 2410
Report from the International Consortium of Health Outcome Measurement Hip and Knee Osteoarthritis Working Group: Consensus on an International Standard Set of Outcomes Measures for Patients with Hip or Knee Osteoarthritis.
Osteoarthritis - Clinical Aspects Poster II: Biomarkers, Biomechanics and Health Services Research- 9:00AM-11:00AM
-
Abstract Number: 2544
Representing the Variability in Patients’ Preferences
Research Methodology Poster (ARHP)- 9:00AM-11:00AM
-
Abstract Number: 2227
Resident’s Guide to Pediatric Rheumatology Mobile App: Assessing Enablers and Barriers of Use through Qualitative Focus Groups
Education Poster II